Diabetes: Secondary Complications, Regulation and Innovation

-

Join your peers at the only conference dedicated to the leading causes of mortality and morbidity in diabetes, this autumn, in London. Our distinguished faculty unite the fields of pharmacology, nanotechnology and clinical medicine to target atherosclerosis, endothelial inflammation and end-stage renal disease.

SMi's unique program brings together the latest research from those at the forefront of attenuating the complications arising from hyperglycaemia, dyslipidaemia, and angiopathy.

“This conference is an excellent one stop shop to up-skill on current issues in diabetes therapy. I’m happy to chair what will no doubt be a very stimulating session.” – Phil Ambery, Medical Director, GlaxoSmithKline

Key Reasons to Attend:
• Receive clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Remain abreast of new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study

Key Speakers Include:
• James F. List, Vice President and Full Development Lead, Dapagliflozin, Bristol-Myers Squibb
• John Wilding, Professor of Medicine & Honorary Consultant Physician, Head of Department of Obesity and Endocrinology, University of Liverpool Hospital
• Martin Siman, Director, Design and Interpretation Centre of Excellence, AstraZeneca
• Philip Ambery, Director, Clinical Development, GlaxoSmithKline
• Sandra Souza, Team Lead, Molecular Biomarkers, PPDM , Merck Sharp & Dohme

Diabetes: Secondary Complications, Regulation and Innovation, promises to be a unique platform for networking, problem solving and learning from timely case studies. This really is a unique event not to be missed.

Click here to find out more and/or book your place.

Location:
Marriott Hotel, Regents Park
UK
UK


Organizer: SMi Group Ltd

1 Oct 2013

UPCOMING FEATURED EVENTS 1 Next 
ELRIG Drug Discovery 20142 Sep 2014 Read
Neuroscience 201415 Nov 2014 Read


ALL UPCOMING EVENTS
1 2 3 Next 
2014 AACC Annual Meeting & Clinical Lab Expo27 Jul 2014 Read
Microscopy & Microanalysis 2014 Meeting3 Aug 2014 Read
248th ACS National Meeting & Exposition10 Aug 2014 Read
ELRIG Drug Discovery 20142 Sep 2014 Read
International Microscopy Congress 20147 Sep 2014 Read
WTG Global Pharma Manufacturing Summit 20148 Sep 2014 Read
Analytical Method Development, Validation and Transfer9 Sep 2014 Read
Cancer Vaccines15 Sep 2014 Read
Stem Cells Regenerative Medicine Congress 201415 Sep 2014 Read
World Cord Blood Congress 201415 Sep 2014 Read
Cell Culture World Congress USA 201415 Sep 2014 Read
WMIC 201417 Sep 2014 Read
12th Annual Pharmaceutical IT Congress22 Sep 2014 Read
2nd Annual Congress of the European Society for Translational Medicine & Global Network Conference on Translational Medicine (EUSTM-2014)22 Sep 2014 Read
MipTec 201423 Sep 2014 Read
Pharmaceutical and Medical Device Packaging and Labelling 201424 Sep 2014 Read
3rd Biomarkers in Diagnostics & Therapeutics 2014 (BDT2014)24 Sep 2014 Read
analytica China24 Sep 2014 Read
5th Annual Biosimilars & Biobetters29 Sep 2014 Read
Microbiology & Infectious Diseases Congress29 Sep 2014 Read
IFBLS - The 31st World Congress of Biomedical Laboratory Science3 Oct 2014 Read
HUPO 20145 Oct 2014 Read
EuroLabFocus 20147 Oct 2014 Read
World Vaccine Congress Europe 201413 Oct 2014 Read
Advances in Cancer Immunotherapies 2014 (ACI2014)15 Oct 2014 Read
ASHG 201418 Oct 2014 Read
Orphan Drugs and Rare Diseases20 Oct 2014 Read
COPD20 Oct 2014 Read
Clinical Trial Supply East Coast 201428 Oct 2014 Read
AAPS Annual Meeting and Exposition2 Nov 2014 Read